Sunday, August 31, 2014

PT Kimia Farma (Persero) Tbk - Pharmacist Kimia Farma September 2014

PT Kimia Farma (Persero) Tbk
PT Kimia Farma (Persero) Tbk / kimiafarma.co.id
PT Kimia Farma (Persero) Tbk - Kimia Farma is Jakarta based pharmaceutical and healthcare company in Indonesia. Kimia Farma running business in pharmaceutical and healthcare industry, including reasearch and development, manufacturing, marketing & distribution, retail, clinic laboratorium and health clinic. Kimia Farma was first established in 1817 as a Dutch Indies company named NV Chemicalien Handle Rathkamp & Co. The Government of Indonesia establish PNF Bhinneka Kimia in 1958 as a merger results of a number of pharmaceutical companies ex Dutch companies. In 1971, NF Bhinneka Kimia Farma was changed into PT Kimia Farma (Persero). The name of PT Kimia Farma (Persero) Tbk was launched in 2001 after listed in Indonesia Stock Exchange under ticker code KAEF. The Company succeeded in achieving acceptable and sound growth in 2013. Total sales went up by 19.05% from Rp2.08 trillion in 2012 to Rp2.47 trillion in 2013. Total net profit continue to grow by 4.59% to Rp214.55 billion from Rp 205.13 billion in 2012. This was stated by Kimia Farma in its 2013 annual report as cited by JobsCDC.com.

To support the bussiness expansion and its organic growth, PT Kimia Farma (Persero) Tbk is looking for experienced highly competent and self motivated profesionals to fill the following position :

Pharmacist

Requirements
  • Minimum education of Apothecary Profession.
  • Minimum GPA of 3.00.
  • Maximum age of 26 years old.
  • Have a good communication skill customer oriented.
  • Computer literate, minimum Microsoft Office application.
  • Willing to be stationed in all over Indonesia.
    For further information about job requirements and to apply online, please refer official source from Jobstreet on following link below. Application will be treated strictly confidential and only short-listed candidates will receive responses. (JobsCDC.com / Source)

    0 comments:

    Post a Comment